Trudell
HFA Transition Provides an Opportunity to Improve Aerobid Inhaler
Published in Medicine and Law Weekly, October 10th, 2008
As the CFC to HFA transition deadline for pressurized metered dose inhalers (MDIs) approaches, Flunisolide, an existing CFC based inhaled corticosteroid (ICS) branded as Aerobid(R), has been reformulated with a non ozone depleting propellant to transition through the CFC phase out. A notable change in Forest's Flunisolide HFA product will be the integration of the AEROCOUNT Dose Indicator to remind patients how much medication remains in their inhaler.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Antibiotics
Researchers from Mayo Clinic detail new studies and findings in the area of antibiotics - Bipolar Disorder
Data on bipolar disorder discussed by researchers at University of Pittsburgh - Epidemiology
Findings in epidemiology reported from College of Medicine - Life Sciences
Investigators at University of Kent publish new data on life sciences - Life Sciences
New life sciences research reported from Center for Health Policy Research and Development - Life Sciences
Researchers at Cornell University, Department of Psychology release new data on life sciences - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
